Related Experiment Video
Updated: Aug 15, 2026
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
[Application of immunotherapy in Catalonia (Spain)]
M J Paniagua1, E Botey, R López-Abad
1Unidad de Alergia, Servicio de Medicina Interna, Hospital Universitario de Tarragona Joan XXIII, Avda. Dr. Mallafré Guasc 4, 43007 Tarragona, Spain.
Insights
Specific immunotherapy (SIT) is widely used for respiratory allergies in Catalonia, primarily via subcutaneous administration. However, optimal dosage and unit creation remain areas for further research.
Area of Science:
- Allergy and Immunology
- Respiratory Medicine
Background:
- Respiratory allergic diseases pose a significant health burden.
- Specific immunotherapy (SIT) is a key treatment modality for these conditions.
Purpose of the Study:
- To assess the current use of SIT in Catalonia, Spain.
- To understand hospital practices and opinions regarding SIT for respiratory allergies.
- To investigate SIT dosage schedules and the establishment of dedicated immunotherapy units.
Main Methods:
- A survey was distributed to allergy unit heads in 24 public and private Catalan hospitals.
- The questionnaire focused on SIT administration, dosage, and unit creation.
- Data analysis of the 18 responding hospitals.
Main Results:
- Subcutaneous administration was the predominant route (89.4%).
- The classical dosage schedule was most frequently employed (77.2%).
- A majority (83.3%) viewed immunotherapy units favorably, but only 44% deemed their creation feasible.
Conclusions:
- This survey outlines current SIT application in Catalonia.
- Key areas requiring further standardization include optimal dosage schedules and administration precautions.
- The feasibility of establishing specialized immunotherapy units needs further consideration.
Background:
The aim of this study was to determine the use of specific immunotherapy (SIT) in public and private hospitals in Catalonia (Spain) in the management of respiratory allergic diseases and opinions about this treatment through a questionnaire. SIT dosage schedules and the creation of immunotherapy units were also investigated.
Methods And Results:
A questionnaire containing eight items was sent by post and/or electronic mail to the heads of allergy units in 24 public and private hospitals in Catalonia.A total of 18 hospitals responded. The most commonly used route of administration was subcutaneous (89.4 %, SD 9.05) and the most widely used dosage schedule was the classical schedule (77.2 %, SD 24.9). Most of the hospitals (83.3 %) believed that immunotherapy units were an advantage but only 44 % of them believed that their creation was feasible.
Conclusions:
The results of this survey identify the application of SIT in Catalonia and reveal certain features of this treatment that remain to be established such as the optimal dosage schedule and the precautions that should be followed when administering SIT.
